The emergence of new therapeutic agents such as Aducanumab, Lecanemab, and Donanemab for Alzheimer’s disease (AD) offers promising prospects for managing this debilitating condition.
The emergence of new therapeutic agents such as Aducanumab, Lecanemab, and Donanemab for Alzheimer’s disease (AD) offers promising prospects for managing this debilitating condition.